Wirth Peter

Insider Reports History

Entity
Company
Location
37 Hancock Street, Boston, MA
Signature
/s/ Bruce Blefeld, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Wirth Peter:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zai Lab Ltd Director American Depositary Shares 383K $8.17M $21.33 Jun 18, 2024 Direct
Syros Pharmaceuticals, Inc. Director Common Stock 16K $79.2K $4.95 Jun 5, 2024 Direct
Syros Pharmaceuticals, Inc. Director Stock Option (right to buy) 6K Jun 5, 2024 Direct
Forma Therapeutics Holdings, Inc. Director Common Stock 0 $5.05 Oct 14, 2022 Direct
Forma Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 0 Oct 14, 2022 Direct

Insider Reports Filed by Wirth Peter

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZLAB Zai Lab Ltd Jun 18, 2024 1 $0 4 Jun 20, 2024 Director
SYRS Syros Pharmaceuticals, Inc. Jun 5, 2024 2 $0 4 Jun 7, 2024 Director
ZLAB Zai Lab Ltd Jun 29, 2023 1 $500K 4 Jun 30, 2023 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2023 2 $0 4 Jun 2, 2023 Director
ZLAB Zai Lab Ltd Dec 8, 2022 2 -$278K 4 Dec 9, 2022 Director
FMTX Forma Therapeutics Holdings, Inc. Oct 14, 2022 7 $0 4 Oct 14, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Sep 16, 2022 2 $0 4 Sep 19, 2022 Director
FMTX Forma Therapeutics Holdings, Inc. Jun 8, 2022 2 $0 4 Jun 9, 2022 Director
SYRS Syros Pharmaceuticals, Inc. Jun 1, 2022 1 $0 4 Jun 2, 2022 Director
ZLAB Zai Lab Ltd Jan 3, 2022 1 $0 4 Jan 4, 2022 Director
ZLAB Zai Lab Ltd Dec 8, 2021 1 $285K 4/A Dec 12, 2022 Director
FMTX Forma Therapeutics Holdings, Inc. Jun 17, 2021 2 $0 4 Jun 21, 2021 Director
SYRS Syros Pharmaceuticals, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director